COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 29, 2020
October 29, 2020

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians
October 29, 2020

Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?

The Obesity Paradox: How Real is It?
October 29, 2020

Carl "Chip" Lavie, MD, author of the original book titled, "The Obesity Paradox" explains the paradox of metabolic health in the obese, how it wanes, and an essential element to maintain it.

New USPSTF Colorectal Cancer Screening Draft Recommendation Includes Adults Aged 45 Years
October 28, 2020

For the first time, the USPSTF recommends colorectal cancer screening in adults beginning at age 45.

4 Questions for PCPs on Prevention and Management of Cardiometabolic Diseases
October 28, 2020

Waist circumference measures, complementary antihypertensives, appropriate exercise levels for T2D patients--test what you know about cardiometabolic risk and management.

COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 28, 2020
October 28, 2020

Global confirmed cases of COVID-19 have surpassed 44 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Stroke Rates Rising Among US Young Adults, yet 1 in 3 Don’t Know Common Symptoms
October 27, 2020

New research shows nearly 30% of US young adults do not know the 5 most common stroke symptoms, almost 3 million are not aware of any symptoms.

What do you Know about Weight Loss Medications?
October 27, 2020

Weight loss is essential to arrest the cardiovascular disease and metabolic dysfunction linked to obesity. What do you know about the drugs now available that may help?

COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 27, 2020
October 27, 2020

How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.

Kidney Week: Dapagliflozin Renoprotective, Cardioprotective in CKD Patients
October 26, 2020

Dapagliflozin is renoprotective and cardioprotective in chronic kidney disease patients, suggests a secondary analysis of the DAPA-CKD trial presented at Kidney Week 2020.